Asia–Middle East corridor gains momentum in healthtech collaboration
Investors urged founders to understand local healthcare structures, insurance systems and patient segments, as well as articulate why their solution matters to the target market.
Independent intelligence on healthtech across Asia and the Middle East
Investors urged founders to understand local healthcare structures, insurance systems and patient segments, as well as articulate why their solution matters to the target market.
Sessions focused on how digital tools and health data are being used to support more preventative and responsive public health approaches.
The CARDIO4Cities programme builds on Brunei’s existing digital health platform, BruHealth, and seeks to use population-wide data and AI to identify high-risk individuals early.
The Chinese AI company is building a dedicated R&D and operations team in Nanning, with a focus on connecting to broader ASEAN markets.
Focus areas include healthy longevity, intelligent health systems for public policy, and large-scale use of digital, data and AI in healthcare.
The initiative is intended to promote collaboration in clinical treatment, research, standardisation, and the medical devices sector, with a focus on the regulated and safe use of digital technologies.
The event highlights the growing role of digital technologies and AI in improving research performance and supporting regulatory and oversight processes.
Talks reviewed the implementation of digital healthcare initiatives and explored opportunities for cooperation in hospital information systems and digital platforms.
ADHRC focuses on areas including personalised medicine, rare diseases and advanced healthcare technologies.